Biofrontera (BFRI) Accumulated Expenses (2020 - 2025)

Biofrontera's Accumulated Expenses history runs 6 years deep, the most recent figure standing at $4.9 million for Q4 2025.

• On a quarterly basis, Accumulated Expenses rose 101.69% year-over-year to $4.9 million in Q4 2025; TTM through Dec 2025 was $4.9 million, a 101.69% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 101.69% from the prior year.
• Accumulated Expenses advanced to $4.9 million in Q4 2025 per BFRI's latest filing, from $3.0 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $11.0 million in Q3 2023 and bottomed at $2.4 million in Q4 2024.
• The 5-year median for Accumulated Expenses is $4.9 million (2025), against an average of $6.0 million.
• Across the five-year window, Accumulated Expenses jumped 256.76% in 2021 and tumbled 70.75% in 2023, its largest moves.
• Year by year, Accumulated Expenses stood at $9.7 million in 2021, then advanced by 12.53% to $10.9 million in 2022, then sank by 58.7% to $4.5 million in 2023, then tumbled by 45.89% to $2.4 million in 2024, then surged by 101.69% to $4.9 million in 2025.
• Per Business Quant, the three latest BFRI Accumulated Expenses figures stand at $4.9 million (Q4 2025), $3.0 million (Q3 2025), and $5.8 million (Q2 2025).